Literature DB >> 6105705

An un-dopamine hypothesis of schizophrenia.

M Alpert, A J Friedhoff.   

Abstract

The dopamine hypothesis of schizophrenia is examined critically. Although the hypothesis is couched in chemical terms, the evidence is primarily pharmacologic. In addition, neuroleptic mechanisms do not fit a simple hyperdopaminergic formulation, and treatment efficacy points to a general psychotic rather than specific schizophrenic role for dopamine. Most compromising to the hypothesis is the therapeutic action of L-dopa when combined with neuroleptics in chronic schizophrenics. Dopamine appears important but cannot be viewed as a simple pathogen.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6105705     DOI: 10.1093/schbul/6.3.387

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  4 in total

Review 1.  Negative symptoms: psychopathological models.

Authors:  J Ananth; A Djenderdjian; P Shamasunder; J Costa; J Herrera; J Sramek
Journal:  J Psychiatry Neurosci       Date:  1991-03       Impact factor: 6.186

2.  [Use of low doses of bromocriptine in chronic schizophrenia resistant to neuroleptics. A preliminary study].

Authors:  M A Wolf; J M Diener; C Lajeunesse; C Shriqui
Journal:  J Psychiatry Neurosci       Date:  1992-06       Impact factor: 6.186

3.  Impaired Prefrontal Cortical Dopamine Release in Schizophrenia During a Cognitive Task: A [11C]FLB 457 Positron Emission Tomography Study.

Authors:  Naren Rao; Georg Northoff; Abanti Tagore; Pablo Rusjan; Miran Kenk; Alan Wilson; Sylvain Houle; Antonio Strafella; Gary Remington; Romina Mizrahi
Journal:  Schizophr Bull       Date:  2019-04-25       Impact factor: 9.306

4.  A study of physical anhedonia as a trait marker in schizophrenia.

Authors:  Shobit Garg; Christoday R J Khess; Sumit Khattri; Preeti Mishra; Sai Krishna Tikka
Journal:  Ind Psychiatry J       Date:  2018 Jul-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.